This paper examines dengue fever as a global public health concern, reviewing its viral etiology, modes of transmission, pathophysiology, and control measures. It then focuses on the molecular epidemiology of dengue outbreaks in Guangzhou, China, specifically investigating whether the 2010 DENV-4 outbreak represented a reemergence of a 1990 strain or an introduced strain. Drawing on patient case histories, geographic data, genotyping, and phylogenetic analysis, the paper concludes that the 2010 outbreak was caused by an imported DENV-4 strain from Thailand rather than a resurgence of the earlier local strain. A glossary of key technical terms is also provided.
The paper demonstrates effective use of molecular epidemiology as an investigative framework. By combining phylogenetic analysis with traditional epidemiological tools — case timelines, geographic mapping, and disease severity data — the author shows how virology can resolve questions about outbreak origins that clinical data alone cannot answer. This cross-method triangulation is a hallmark of rigorous public health research writing.
The paper opens with a global overview of dengue fever, then covers etiology, pathophysiology, and control measures in dedicated sections, establishing scientific grounding. The molecular epidemiology section forms the analytical core, presenting the Guangzhou DENV-4 case study in detail. The discussion synthesizes all evidence to reach a clear conclusion. The appended glossary adds practical value for readers unfamiliar with virology terminology.
Dengue is a viral disease transmitted from host to host by mosquitoes (Shepherd, 2012, Background). Many tropical and subtropical regions of the world are currently combating this disease, including 112 countries in the Americas, Africa, Asia, and Australia. These regions are home to almost 3 billion people; therefore, nearly half of the world's population is at risk of becoming infected with dengue. Currently, between 50 and 100 million people become infected with the virus each year.
Unfortunately, the number of reported cases of dengue fever is increasing in many of these regions, including the Americas, South-East Asia, and the Western Pacific (Shepherd, 2012, Background). This paper reviews what is understood about this disease, its mode of transmission, ongoing efforts to control its spread, and how public health virologists track outbreaks.
The virus that causes dengue fever is a single-stranded RNA virus encoded by an 11-kilobase genome encased within an icosahedral nucleocapsid (Shepherd, 2012, Etiology). This capsid is in turn encapsulated by a lipid envelope. There are currently four main serotypes of dengue: DENV-1, DENV-2, DENV-3, and DENV-4. The serotypes are distinguished from one another using distinct antibodies and can be further divided into several genotypes. These different serotypes and genotypes are important because they appear to influence disease severity.
High-risk areas for dengue infection tend to be regions with a humid climate, because the primary vector for its transmission, Aedes aegypti, thrives in such environments (Shepherd, 2012, Etiology). These mosquitoes inhabit urban areas where there is poor sanitation, because discarded man-made waste — such as old tires — traps water, which then acts as a breeding ground (Shepherd, 2012, Background). Ae. aegypti can become infected with the dengue virus when it feeds on an infected human or primate. Once infected, the virus begins to replicate within the organs and body cavity of the insect. Ae. aegypti will remain infected for the duration of its lifespan, which averages 21 days; however, under desiccating conditions, infected Ae. aegypti eggs can serve as a potential source of vertical transmission for as long as a year.
The incubation period of the virus in a human host is 3–14 days, with an average of a week or less (Shepherd, 2012, Pathophysiology). The virus targets dendritic cells, hepatocytes, and endothelial cells for infection and replication, which in turn activates an immune response to clear the body of the virus. However, most infected individuals will not develop symptoms. The people most susceptible to developing symptoms are those who have never previously encountered dengue, such as recent tourists or immigrants to endemic regions. People who do become symptomatic will suffer primarily from a fever lasting about a week. Other symptoms can include severe headache, eye pain, severe joint and muscle pain, nausea and vomiting, and rash (NIAID, 2007). Full recovery occurs shortly thereafter, unless the patient develops hemorrhagic fever or dengue shock syndrome.
Children below the age of 15 are particularly susceptible to developing hemorrhagic fever, although all ages are equally prone to developing this condition on the American continent and in Taiwan (Shepherd, 2012, Pathophysiology). Individuals who develop hemorrhagic fever will first experience a high fever lasting 2–7 days, followed by a period of remission, after which they will again become febrile and develop hemorrhagic disease. This manifestation of dengue is potentially lethal because it can lead to plasma leaking, fluid accumulation, respiratory distress, severe bleeding, organ failure (WHO, 2012), and/or circulatory failure (Shepherd, 2012, Pathophysiology). One of the telltale signs, in addition to the biphasic fever, is bone pain, which is believed to result from the destruction of bone marrow precursor cells. Hemorrhagic fever affects over half a million people each year, contributing to approximately 25,000 yearly dengue-related deaths (reviewed by Jing et al., 2012).
The most dangerous form of the disease is dengue shock syndrome, which occurs primarily in children who are infected with the virus a second time (NIAID, 2007). In addition to the above symptoms, massive bleeding leads to hypotension and then shock. Without access to medical care, this condition is frequently fatal.
Dengue has become entrenched in over 100 countries around the world, making it both endemic to those countries and one of the most difficult-to-control diseases globally (TDR, 2011). A five-year study conducted across five Asian countries investigated the efficacy of measures designed to bring the disease under control. The interventions included mechanical covers for water containers, chemical pesticides, biopesticides, introduction of mosquito larvae predators, and improved solid waste management.
The genetic differences among the four main serotypes are significant for several reasons. A first infection with the virus confers lifelong immunity against the offending serotype, but not against the other three (Weaver and Vasilakis, 2009). Furthermore, the increased risk of developing hemorrhagic disease or dengue shock upon reinfection is consistent with the possibility that some serotypes produce more severe disease. For example, DENV-4 has been correlated with more severe disease in children — and, to a lesser extent, in adults — following secondary infection (reviewed by Jing et al., 2012). DENV-4 occurs most frequently as a secondary infection and is responsible for 10% of hemorrhagic disease cases in Thai children.
A DENV-4 outbreak was first identified in Guangzhou, China in 1978, and subsequent outbreaks occurred in 1990 and 2010 (reviewed by Jing et al., 2012). Guangzhou is a large metropolitan area with a subtropical, humid climate where all four serotypes have emerged in the past. To determine whether the 2010 outbreak represented a reemergence of the 1990 DENV-4 strain, researchers investigated the genotypes and phylogenetic relationships among viruses collected from individual dengue cases.
The primary vector for dengue transmission in Guangzhou is Aedes albopictus (Jing et al., 2012). Larval surveys indicated a high prevalence of this arthropod at the time of the 2010 outbreak. A total of 19 dengue fever cases were identified, of which one was determined to be imported from Bangkok, Thailand. The individual suspected of importing dengue returned to the Jingtai Street district in Guangzhou on September 2, 2010, having begun to experience symptoms on the evening of August 31. The indigenous cases occurred between September 6 and October 29, 2010, and all cases were confined to the Jingtai Street community. Hospitalization was required in 16 of the 19 cases, consistent with a more severe form of the disease. The timing of the cases, the limited geographic distribution, and the uniform disease severity together suggest that the Guangzhou 2010 outbreak was introduced from Thailand.
Viral isolates were available for five cases, and all were determined to be DENV-4 (Jing et al., 2012). Sequencing of the envelope gene — the prototypical reference sequence for dengue genotyping — indicated 99.9% to 100% homology among all five cases. Sequence comparisons with GenBank database entries indicated Thailand was the most likely source.
When compared to another DENV-4 sequence isolated from Guangzhou in 2010 that had been previously deposited in GenBank, both sequences were found to be phylogenetically identical (Jing et al., 2012). Both belong to the same clade and to DENV-4 genotype II. However, comparison with the reference sequence from the 1990 DENV-4 outbreak did not reveal strong homology. A phylogenetic comparison with a Thailand strain isolated from a 2002 outbreak revealed strong homology, consistent with that strain representing the parent lineage. These results suggest there was no phylogenetic relationship between the Guangzhou DENV-4 outbreaks of 1990 and 2010; therefore, the 2010 outbreak represented an introduced strain rather than a reemergence.
You’re 77% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.